Janux Therapeutics (NASDAQ: JANX)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Janux Therapeutics (NASDAQ: JANX) through any online brokerage.
The latest price target for Janux Therapeutics (NASDAQ: JANX) was reported by B of A Securities on Tuesday, July 6, 2021. The analyst firm set a price target for 35.00 expecting JANX to rise to within 12 months (a possible 196.61% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Janux Therapeutics (NASDAQ: JANX) is $11.8 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Janux Therapeutics.
Janux Therapeutics’s Q2 earnings are confirmed for Tuesday, August 9, 2022.
There is no upcoming split for Janux Therapeutics.
Janux Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.